Cardinal Health, Inc DCF Stock Analysis. Buy or Sell?

Cardinal Health, Inc DCF Stock Analysis. Buy or Sell?

Cardinal Health, Inc. DCF Stock Analysis.

Here’s my assumptions:

Risk Free Rate (10 Years Interest Rate Swap): 3.92%

Risk Premium (Taken from the Aswath Damodaran equity premium spreadsheet): 4.62%

Interest Rate Spread on The Risk free rate ( For the cost of debt calculation): 8.5%

Historical Data

Revenue growth in the last 10 years (CAGR): 6.27%

Earnings growth in the last 10 years (CAGR): 0.90%

Unlevered Free Cash Flow growth in the last 10 years (CAGR): 3.91%

Future Assumptions

End of Year FCF growth: 3%

Growth until end of 2026: 3%

Growth until end of 2034: 3%

Perpetual growth: 2.5%

Net Debt: 6.250B

Outstanding Stock Options Present Value Assumption: $0B

Restricted Stock Units Present Value Assumption: $0.649B

Stock Valuation based on these assumptions: $350

Last update 02/22/2026

All the content in this newsletter should be taken as informational content only. THIS IS NOT FINANCIAL ADVICE! Do your own Due Diligence before investing or contact a professional financial advisor.

I don’t have a position in Cardinal Health, Inc. (CAH) and I don’t plan to add a position in the coming days.